News

Russia's Sputnik-V COVID-19 vaccine might become available for supply as early as next month, the country's sovereign wealth fund RDIF's top official told ThePrint. According to Kirill Dmitriev, the Chief Operating Officer (COO) of RDIF, they are hoping for approval...

Russia's permanent mission to the UN and the Health Ministry will hold a presentation, which will provide detailed information on the Russian vaccine against the novel coronavirus disease (COVID-19), mission spokesman Fyodor Strzhizhovsky told Sputnik. During a speech at the...

Algernon Pharmaceuticals, a clinical stage pharmaceutical development company, announced that the final patient has been enrolled in its multinational phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19. The aggregate total number of patients enrolled from...

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions (Sterling), has announced a new strategic partnership with ADC Biotechnology (ADC Bio), a UK based biotechnology company specialising in antibody drug conjugates. The partnership will see Sterling make a significant...

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced that the United States FDA has granted Fast Track designation for remestemcel-L in the treatment of acute respiratory distress syndrome (ARDS) due to COVID-19 infection. Fast Track...

Janssen Inc. the pharmaceutical companies of Johnson & Johnson, has initiated a rolling submission with Health Canada for its investigational single-dose vaccine candidate for the prevention of COVID-19. Health Canada announced a rolling review of the investigational single-dose Janssen COVID-19...

EMA has received an application for conditional marketing authorisation (CMA) for BNT162b2, a COVID?19 mRNA vaccine developed by BioNTech and Pfizer. The assessment of BNT162b2 will proceed under an accelerated timeline. An opinion on the marketing authorisation could be...